(Q35145586)

6 August 2017

1 reference

title

Androgens and the ageing male and female (English)

1 reference

6 August 2017

Maria A Yialamas

1

1 reference

PubMed ID

12787549

6 August 2017

Frances J Hayes

series ordinal

2

1 reference

6 August 2017

1 June 2003

1 reference

Best Practice and Research: Clinical Endocrinology and Metabolism

6 August 2017

1 reference

6 August 2017

17

1 reference

6 August 2017

2

1 reference

6 August 2017

223-236

1 reference

Über die chemische Untersuchung der Sexualhormone

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Testosterone secretion and metabolism in male senescence

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Loss of circadian rhythmicity in blood testosterone levels with aging in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Reproductive functions in young fathers and grandfathers

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

The gonadotropin-suppressive activity of androgen is increased in elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

The effect of human chorionic gonadotropin on plasma steroid levels in young and old men.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Further Studies on Leydig Cell Function in Old Age

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Errors in the measurement of plasma free testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Androgen effects on bone metabolism: recent progress and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Androgen and progestagen effects on plasma lipids

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Sex hormones, insulin, lipids, and prevalent ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Androgen treatment of abdominally obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Effects of androgen treatment in impotent men with normal and low levels of free testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Secondary hypogonadism in older men: its relation to impotence

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Decreased bioavailable testosterone in aging normal and impotent men

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Treatment of male hypogonadism with testosterone enanthate

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

An analysis of testosterone implants for androgen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

7Alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Obstructive sleep apnea syndrome induced by testosterone administration

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Reversible reproductive dysfunction in men with obstructive sleep apnoea.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Report of National Institute on Aging Advisory Panel on Testosterone Replacement in Men.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Serum Androstenedione and Testosterone Levels During the Menstrual Cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Hormonal profiles after the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Hormonal dynamics associated with the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Hysterectomy, Oophorectomy, and Endogenous Sex Hormone Levels in Older Women: The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Effects of Estrogen, Androgen, and Progestin on Sexual Psychophysiology and Behavior in Postmenopausal Women*

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Transdermal Testosterone Administration in Women with Acquired Immunodeficiency Syndrome Wasting: A Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Transdermal testosterone treatment in women with impaired sexual function after oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2803%2900018-6

7 January 2021

10.1016/S1521-690X(03)00018-6

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12787549